Title : Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE-/- mice.

Pub. Date : 2020 Nov 15

PMID : 32828944






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE-/- mice. Raloxifene Hydrochloride interleukin 6 Mus musculus
2 Our previous studies found that Raloxifene targeted against IL-6/GP130 protein-protein interface and inhibited STAT3 phosphorylation induced by IL-6 in cancer cells. Raloxifene Hydrochloride interleukin 6 Mus musculus
3 Our previous studies found that Raloxifene targeted against IL-6/GP130 protein-protein interface and inhibited STAT3 phosphorylation induced by IL-6 in cancer cells. Raloxifene Hydrochloride interleukin 6 Mus musculus
4 However, whether Raloxifene could suppress IL-6/STAT3 signaling pathway and attenuate atherosclerosis in high-fat diet (HFD)-induced mice remains unknown. Raloxifene Hydrochloride interleukin 6 Mus musculus
5 Histological analysis showed that the expression of IL-6, P-STAT3, ICAM-1, VCAM-1, CD68 and alpha-SMA were significantly decreased in the Raloxifene intervention group compared to HFD group. Raloxifene Hydrochloride interleukin 6 Mus musculus
6 Moreover, we observed that IL-6 increased migration and cell viability of VSMCs and RAW264.7 cells, while Raloxifene treatment decreased migration and reduced cell viability of VSMCs and RAW264.7 cells stimulated by IL-6. Raloxifene Hydrochloride interleukin 6 Mus musculus
7 SIGNIFICANCE: Raloxifene has effects on inhibiting atherosclerosis development, the underlying mechanisms might involve in inhibiting inflammation-related IL-6/STAT3 signaling pathway. Raloxifene Hydrochloride interleukin 6 Mus musculus